Pharmaceuticals

Global Peptide Therapeutics Industry Trends and Market Forecast 2026–2030

February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the peptide therapeutics market from 2026–2035 with trusted insights from The Business Research Company

How much is the Peptide Therapeutics Market valued at in 2026, and what valuation is forecast for 2030?

The peptide therapeutics market has experienced rapid expansion in recent years. It is projected to grow from $49.21 billion in 2025 to $54.62 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.0%. The historical increase in this market can be linked to the initial acceptance of peptide drugs, the evolution of peptide synthesis techniques, a rise in the occurrence of chronic and rare diseases, breakthroughs in pharmacology and biochemistry, and the proliferation of contract research organizations.

The peptide therapeutics market size is anticipated to undergo significant growth in the upcoming years, with projections indicating it will reach $83.57 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.2%. This expansion during the forecast period is fueled by several factors, including the ascent of personalized medicine, increased investment in peptide-based therapeutics, the integration of artificial intelligence in drug discovery processes, the broadening of biologics manufacturing capabilities, and the rising demand for healthcare solutions in emerging markets. Noteworthy trends expected over this period encompass the development of targeted peptide drugs, innovations in peptide drug delivery systems, the emergence of multi-functional peptide therapeutics, advances in natural peptide extraction and synthesis methods, and the application of combination therapies that incorporate peptides.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7216&type=smp

What Drivers Are Influencing The Growth Of The Peptide Therapeutics Market?

The increasing incidence of chronic diseases is projected to propel the growth of the peptide therapeutics market. These illnesses are prolonged health issues that are often incurable, yet can sometimes be managed or even cured. The rise in chronic diseases is attributed to factors like increased use of tobacco products, poor nutrition, physical inactivity, excessive alcohol consumption, among others. Peptide therapeutics are beneficial in the prevention and treatment of certain chronic diseases. For instance, in January 2023, according to the National Library of Medicine, a US-based agency, the number of individuals in the US aged 50 and older with at least one chronic condition is anticipated to increase by 99.5%, totaling 142.66 million, by 2050. Therefore, the escalating prevalence of chronic diseases is expected to drive the peptide therapeutics market during the forecast period.

How Is The Peptide Therapeutics Market Organized Into Various Segments?

The peptide therapeutics market covered in this report is segmented –

1) By Type: Generic, Branded

2) By Route of Administration: Parenteral, Mucosal, Oral, Transdermal

3) By Application: Cancer, Cardiovascular Diseases, Central Nervous Systems, Metabolic Disorders, Infections, Hematological Disorders, Gastrointestinal Disorders, Dermatology, Respiratory Disorders, Acromegaly, Other Applications

Subsegments:

1) By Generic: Generic Peptide Drugs, Biosimilars

2) By Branded: Innovative Peptide Drugs, Patent-Protected Peptides

What Trends Are Projected To Support The Growth Of The Peptide Therapeutics Market?

Leading companies active in the peptide therapeutics market are concentrating on introducing advanced solutions, such as the cell culture process, to gain a competitive advantage. The cell culture process involves cultivating cells outside their natural environment under controlled conditions, which entails isolating target cells from living tissue and subsequently maintaining them. For example, in June 2023, Evonik Industries AG, a German-based specialty chemicals company, unveiled cQrex KC. cQrex KC is a next-generation peptide for biopharma applications, specifically designed for the cell culture process utilized in manufacturing biological drugs. It allows cell culture process developers to optimize cystine supply and improve cell culture productivity. cQrex KC supports the advancement of vaccines, viral vectors, and cell therapies.

Who Are The Top-Performing Companies In The Peptide Therapeutics Market In Recent Years?

Major companies operating in the peptide therapeutics market are Pfizer Inc., Jhonson & Jhonson, Abbvie Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca plc, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk AS, Teva Pharmaceuticals Industries Ltd., Bachem Holding AG, PolyPeptide Laboratories BV, Arcus Biosciences Inc., Pepscan Therapeutics, Peptech Inc., Peptide Logic Inc., SELLAS Life Sciences Group, Ever Neuro Pharma GmbH, Zealand Pharma AG, PepGen Inc., Pepticom S.A., Peptide Technologies Corporation, SynPeptide Inc., Peptimmune Inc., Merck & Co Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Which Region Currently Holds The Largest Share Of The Peptide Therapeutics Market?

North America was the largest region in the peptide therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Peptide Therapeutics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7216&type=smp

Browse Through More Reports Similar to the Global Peptide Therapeutics Market 2026, By The Business Research Company

Peptide Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-therapeutics-global-market-report

Peptide Synthesis Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-synthesis-global-market-report

Peptide Based Metabolic Disorders Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/peptide-based-metabolic-disorders-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795